Mindray's most Invested R&D Center Announced Construction
The project includes two major subprojects of Wuhan Research Institute and Manufacturing Center. The total net area is about 271 mu（18 hectacres）and the total construction area is about 620,000 square meters. Wuhan Research Institute and Wuhan Manufacturing Center will become Mindray’s second largest R&D center upon completion.
Li Xiting, Chairman of Mindray, Cheng Minghe, President of Mindray and Li Zaiwen, Senior Vice President of Mindray, together with Vice President and General Manager of Wuhan Research Institute Huang Haitao, and Executive Vice President Liu Laiping attended the groundbreaking ceremony. Wang Zhonglin, party chief of Wuhan and the city’s mayor Zhou Xianwang were also present.
“The implementation of Mindray Wuhan Center is gathering the upstream and downstream industrial chains, helping Wuhan build a biomedical and medical device industry cluster, and accelerating the promotion of 'Big Health industry' development", said Mr. Zhou, the city's mayor.
Settled down in the Jiulong Industrial Base of Optics Valley Biolake, Mindray Wuhan Manufacturing Center is designed to become equipment manufacturing centers and engineering centers for orthopedic surgery (surgical robots), minimally invasive surgery and “Big Health”, reagent manufacturing center, biological raw material preparation center and supporting facilities. The industrial output value is expected to be no less than RMB 3 billion when the base is in full operation.
Open WeChat and Scan the QR code .Get the Webpage and Share on Moments.
Mindray Launches New BeneFusion e Series Infusion Systems, Delivering Efficiency in Every Droplet2021-02-02
Mindray Transforms Spot Check Patient Monitoring with New VS Series Vital Signs Monitors2021-01-29
Mindray in Global Actions to Combat COVID-19: Mindray at CMEF 20202020-10-20
Mindray Brings Groundbreaking New Systems to the High-End Anesthesia System Market2020-10-15
BC-7500 CRP, Empowering Pediatric Care2020-08-31